VOLITIONRX LTD — Director's Dealing 2020

Jul 23, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2020-07-21

Reporting Person: Faulkes Martin Charles (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-21	Common Stock	M	30000	$2.5	Acquired	1591284	Direct
2020-07-21	Common Stock	F	24164	$3.95	Disposed	1567120	Direct
2020-07-21	Common Stock	M	30000	$3	Acquired	1597120	Direct
2020-07-21	Common Stock	F	26177	$3.95	Disposed	1570943	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-21	Stock Option (Right to Buy)	$2.5	M	30000	Disposed	2020-08-18	Common Stock (30000)	Direct
2020-07-21	Stock Option (Right to Buy)	$3	M	30000	Disposed	2020-08-18	Common Stock (30000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	356000	Indirect

Footnotes

F1: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise and to satisfy the tax withholding obligations of the Reporting Person. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction.

F2: These shares of Common Stock are beneficially owned by The Dill Faulkes Educational Trust Limited ("DFET"), a UK registered charity. Mr. Faulkes serves as the chairman, director and trustee of DFET and shares voting and dispositive control over these shares but disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.